The latest biotech news

News and Trends 1 Feb 2015

Phenex sells out its main programme to Gilead

Gilead Sciences announces the acquisition of Phenex Pharmaceuticals’ development program for non-alcoholic steatohepatitis (NASH) and other liver diseases. Gilead Sciences and Phenex Pharmaceuticals announced the signing of a definitive agreement under which Gilead will acquire Phenex’s Farnesoid X Receptor (FXR) program comprising small molecule FXR agonists for the treatment of liver diseases including non-alcoholic steatohepatitis […]

February 1, 2015 - 3 minutesmins - By Lourdes Riquelme

News and Trends 31 Jan 2015

An Anglo-French Partnership To Cure Hepatitis B

European biotechnology company Valneva and UK company Immune Targeting Systems (ITS) announced that they have signed an exclusive worldwide commercial license agreement. This deal grants ITS the rights to research, develop and commercialize Hepatitis B vaccine candidates in combination with Valneva’s IC31 Adjuvant. Valneva’s IC31 Adjuvant is a unique synthetic adjuvant combining the immuno-stimulating properties […]

January 31, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 30 Jan 2015

The Human Protein Atlas: exploring human geography

Some 20 years ago, before the genomic era, isolating a protein and identifying the tissue where it was present was enough to get a PhD. Swedish researchers just did it for all the proteins in the human body: the equivalent of 20,000 thesis from the pregenomic age, at a stroke. Thanks to the ‘omics’, the […]

January 30, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 27 Jan 2015

Italian Genenta Science’s Original Strategy to Treat Cancer

Tumor microenvironment, including tumor-associated macrophages, plays a key role in controlling tumor progression and response to therapies. It stimulates tumor growth, supports angiogenesis and tissue remodeling, as well as neutralizes host immunity. Genenta Science is using this mechanism, which is certainly a promising area of cancer biology for the identification of new therapeutic targets. In […]

January 27, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 26 Jan 2015

Is Gecko’s Bio-inspired Glue going to revolutionize Heart Surgery and Tissue Repair?

Imagine you could use a glue to fix a hole or week zone inside your body. Sound promising? Definitely. A new generation of adhesive has been discovered. It can be used in a highly challenging environment and be activated by light. The illustration below shows you how it could be used in heart surgery. The […]

January 26, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 24 Jan 2015

Important Bilateral Academic Agreement for the Future of iPS Cell Therapy

The UK Cell Therapy programme Catapult, which is focused on the development of the UK cell therapy industry to increase the nation’s health and wealth, has signed a patent licence agreement with iPS Academia Japan. It represents a pivotal step in the development of the UK’s GMP induced pluripotent stem (iPS) cell bank. Under the […]

January 24, 2015 - 3 minutesmins - By Lourdes Riquelme

News and Trends 23 Jan 2015

A glimpse of the future: the revolution of bionic eyes

Six months after the surgery, the first Spanish with a bionic eye has gone from the total darkness to discern shapes and distances thanks to the technology developed by Second Sight Medical Products. With the MedTech field moving forward so fast, a new generation of devices meant to restore the sense of vision is about […]

January 23, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 22 Jan 2015

Novabiotics Tackles Antibiotic Resistance by Raising €6,5M Euros

NovaBiotics Ltd has raised €6,5M for priority clinical stage first-in-class antimicrobial therapeutics assets. The private placement with Woodford Investment Management LLP was arranged by Shore Capital as financial adviser and broker to the company. NovaBiotics is a clinical-stage biotechnology company focused on the design and development of first-in-class anti-infectives for difficult-to-treat, medically unmet diseases. NovaBiotics has spent more than 10 […]

January 22, 2015 - 2 minutesmins - By Julie Lellouche

News and Trends 21 Jan 2015

Review: The CRISPR’s Therapeutical revolution

Six years ago, a new sophisticated prokaryotic defense system, was identified in the structure complex CRISPR-Cas9 (CRISPR, clustered regularly interspaced short palindromic repeats; Cas, CRISPR associated nuclease). “Resistance is acquired by incorporating short stretches of invading DNA sequences in genomic CRISPR loci ” Brouns, S. J. J., et al. (2008). The CRISPR repeat sequence has […]

January 21, 2015 - 4 minutesmins - By Cédric Brock

News and Trends 20 Jan 2015

Will Microalgaes solve the Rare Earth conflict?

The extraction of rare earths is a very expensive process, having dramatic consequences for the planet (degradation, impacts on water quality, etc.). Currently, China controls 95% of the World production of these minerals widely used in the field of new technologies and electronics. The development of new methods of sustainable recycling from waste and environmentally friendly is […]

January 20, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 17 Jan 2015

Qiagen, the new giant in next-gen sequencing tools?

Yet again, a new acquisition in this beginning of 2015. Enzymatics, the Boston-area based Biotech company and leading provider of enzymes for Next-gen sequencing, has been acquired by Qiagen for a non-disclosed amount. The amount must be pretty high since Enzymatics’ enzymes are used in 80% of all NGS reactions and the company counts over 150 employees. […]

January 17, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 13 Jan 2015

Roche spent $1B for the Leading Molecular Information Biotech company: Foundation Medicine

2015 starts in a rush for the Biotech industry. Swiss Pharma-giant Roche just announced paying $1B to acquire 56% percent of leading molecular information and genomic analysis Biotech company Foundation Medicine. Foundation Medicine is a leading Biotech company in the field of molecular information and genomic analysis. It uses next-gen sequencing technology and solid bioinformatic analysis […]

January 13, 2015 - 2 minutesmins - By Philip Hemme

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

News and Trends

Phenex sells out its main programme to Gilead

An Anglo-French Partnership To Cure Hepatitis B

The Human Protein Atlas: exploring human geography

Italian Genenta Science’s Original Strategy to Treat Cancer

Is Gecko’s Bio-inspired Glue going to revolutionize Heart Surgery and Tissue Repair?

Important Bilateral Academic Agreement for the Future of iPS Cell Therapy

A glimpse of the future: the revolution of bionic eyes

Novabiotics Tackles Antibiotic Resistance by Raising €6,5M Euros

Review: The CRISPR’s Therapeutical revolution

Will Microalgaes solve the Rare Earth conflict?

Qiagen, the new giant in next-gen sequencing tools?

Roche spent $1B for the Leading Molecular Information Biotech company: Foundation Medicine

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!